{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:56:02Z","timestamp":1787748962796,"version":"build-2784847793"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU-FFR-2024-2043-02"],"award-info":[{"award-number":["NBU-FFR-2024-2043-02"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.prp.2024.155226","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T17:16:21Z","timestamp":1709140581000},"page":"155226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Beyond the genome: MALAT1's role in advancing urologic cancer care"],"prefix":"10.1016","volume":"256","author":[{"given":"Mohd","family":"Imran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Abida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Eltaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Irfan","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehnaz","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mohammed Basheeruddin","family":"Asdaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Al-Hajeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemah Abdulaziz","family":"Alhakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Farhan","family":"AlQarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf A.","family":"Abdulkhaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155226_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120984","article-title":"Curcumin in the treatment of urological cancers: therapeutic targets, challenges and prospects","volume":"309","author":"Hashemi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2024.155226_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0391560319846012","article-title":"Lifestyle in urology: cancer","volume":"86","author":"Emilio","year":"2019","journal-title":"Urologia"},{"key":"10.1016\/j.prp.2024.155226_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.urolonc.2019.01.008","article-title":"Urological cancers and lifestyle: nudging patients toward healthy behaviors","volume":"37","author":"Parsons","year":"2019","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib4","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155226_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000165","article-title":"Checkpoint inhibitors in the treatment of urological malignancies","volume":"2","author":"Popovic","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.prp.2024.155226_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jjco\/hyw034","article-title":"Urologic cancer in China","volume":"46","author":"Pang","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2017.09.004","article-title":"Adjuvant therapy in renal cell carcinoma","volume":"60","author":"Massari","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2024.155226_bib9","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11946","article-title":"Functions of circular RNAs in bladder, prostate and renal cell cancer (Review)","volume":"23","author":"Yang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2024.155226_bib11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/JU.0000000000000117","article-title":"Targeting metastatic hormone sensitive prostate cancer: chemohormonal therapy and new combinatorial approaches","volume":"201","author":"Damodaran","year":"2019","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003743","article-title":"Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067","volume":"9","author":"Regan","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib13","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.cmet.2021.08.012","article-title":"The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy","volume":"33","author":"Wei","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2024.155226_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2019.04.002","article-title":"Management of metastatic bladder cancer","volume":"76","author":"Nadal","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2024.155226_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127375","article-title":"A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies","volume":"253","author":"Thapa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2024.155226_bib16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.prp.2024.155226_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.18.00537","article-title":"Bladder preservation with twice-a-day radiation plus fluorouracil\/cisplatin or once daily radiation plus gemcitabine for muscle-invasive bladder cancer: NRG\/RTOG 0712-a randomized phase II trial","volume":"37","author":"Coen","year":"2019","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib18","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2024.155226_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/em.22472","article-title":"LncRNA polymorphisms and urologic cancer risk","volume":"63","author":"Abdi","year":"2022","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.prp.2024.155226_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154738","article-title":"Long non-coding RNAs in lung cancer: unraveling the molecular modulators of MAPK signaling","volume":"249","author":"Hussain","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154736","article-title":"Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer","volume":"249","author":"Thapa","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.4155\/fmc-2023-0164","article-title":"New horizons in lung cancer management through ATR\/CHK1 pathway modulation","volume":"15","author":"Thapa","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.prp.2024.155226_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2024.155226_bib25","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3892\/ol.2016.4901","article-title":"The function of homeobox genes and lncRNAs in cancer","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020632","article-title":"The functions and unique features of LncRNAs in cancer development and tumorigenesis","volume":"22","author":"Taniue","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2022042088","article-title":"Exploring the mechanical perspective of a new anti-tumor agent: melatonin","volume":"42","author":"Rohilla","year":"2023","journal-title":"J. Environ. Pathol., Toxicol. Oncol.: Off. Organ Int. Soc. Environ. Toxicol. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib28","article-title":"Novel Insights Into MALAT1 Function as a MicroRNA Sponge in NSCLC","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib29","article-title":"The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression","volume":"137","author":"Su","year":"2021","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1615\/JEnvironPatholToxicolOncol.2022042983","article-title":"Recent developments and challenges in molecular-targeted therapy of non-small-cell lung cancer","volume":"42","author":"Rohilla","year":"2023","journal-title":"J. Environ. Pathol., Toxicol. Oncol.: Off. Organ Int. Soc. Environ. Toxicol. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3892\/ol.2021.12604","article-title":"Pathways and role of MALAT1 in esophageal and gastric cancer","volume":"21","author":"Syllaios","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib32","doi-asserted-by":"crossref","first-page":"8273648","DOI":"10.1155\/2018\/8273648","article-title":"An overview of long noncoding RNAs involved in bone regeneration from mesenchymal stem cells","volume":"2018","author":"Peng","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.prp.2024.155226_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154908","article-title":"Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: a review","volume":"252","author":"Hussain","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2164-8-39","article-title":"A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains","volume":"8","author":"Hutchinson","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.prp.2024.155226_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbagrm.2015.06.003","article-title":"Long noncoding RNAs: re-writing dogmas of RNA processing and stability","volume":"1859","author":"Wilusz","year":"2016","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.prp.2024.155226_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.celrep.2012.06.003","article-title":"The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult","volume":"2","author":"Zhang","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2024.155226_bib37","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/emboj.2010.199","article-title":"A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression, The","volume":"29","author":"Bernard","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2024.155226_bib38","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Ji","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155226_bib39","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4161\/rna.21089","article-title":"Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development","volume":"9","author":"Ei\u00dfmann","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.prp.2024.155226_bib40","article-title":"MALAT1: a key regulator in lung cancer pathogenesis and therapeutic targeting","volume":"253","author":"Bhat","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib41","first-page":"19","article-title":"MALAT1: A long non-coding RNA highly associated with human cancers","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124832","article-title":"The pyroptotic role of Caspase-3\/GSDME signalling pathway among various cancer: a review","volume":"242","author":"Bhat","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2024.155226_bib43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2008.10.012","article-title":"3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA","volume":"135","author":"Wilusz","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155226_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molcel.2009.01.026","article-title":"An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles","volume":"33","author":"Clemson","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2024.155226_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2014.02.060","article-title":"Identification of a chemical inhibitor for nuclear speckle formation: implications for the function of nuclear speckles in regulation of alternative pre-mRNA splicing","volume":"446","author":"Kurogi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2024.155226_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154773","article-title":"Probing the links: Long non-coding RNAs and NF-\u03baB signalling in atherosclerosis","volume":"249","author":"Hussain","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109735","article-title":"A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer","volume":"351","author":"Subramaniyan","year":"2022","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.prp.2024.155226_bib48","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1101\/gad.204438.112","article-title":"A triple helix stabilizes the 3\u2032 ends of long noncoding RNAs that lack poly(A) tails","volume":"26","author":"Wilusz","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155226_bib49","doi-asserted-by":"crossref","first-page":"19202","DOI":"10.1073\/pnas.1217338109","article-title":"Formation of triple-helical structures by the 3\u2032-end sequences of MALAT1 and MEN\u03b2 noncoding RNAs","volume":"109","author":"Brown","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2024.155226_bib50","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1038\/s41598-017-09818-6","article-title":"Fine particulate matter 2.5 exerted its toxicological effect by regulating a new layer, long non-coding","volume":"7","author":"Huang","year":"2017","journal-title":"RNA, Sci. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib51","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijcard.2015.10.019","article-title":"Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy","volume":"202","author":"Zhang","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.prp.2024.155226_bib52","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/jcmm.17835","article-title":"MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jmcb\/mjw003","article-title":"Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity","volume":"8","author":"Gast","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2024.155226_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119689","article-title":"Sodium alginate based drug delivery in management of breast cancer","volume":"292","author":"Shaikh","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.prp.2024.155226_bib55","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949684","article-title":"The tRNA-like small noncoding RNA mascRNA promotes global protein translation","volume":"21","author":"Lu","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.prp.2024.155226_bib56","doi-asserted-by":"crossref","first-page":"29365","DOI":"10.1074\/jbc.M114.572693","article-title":"Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2024.155226_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122788","article-title":"Polysaccharide-based nanomedicines targeting lung cancer","volume":"14","author":"Bhat","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2024.155226_bib58","doi-asserted-by":"crossref","first-page":"36045","DOI":"10.1038\/srep36045","article-title":"HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib59","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","article-title":"The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation","volume":"39","author":"Tripathi","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2024.155226_bib60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mc.22919","article-title":"The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing","volume":"58","author":"Gordon","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2024.155226_bib61","article-title":"From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression","volume":"253","author":"Thapa","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","article-title":"Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation","volume":"77","author":"Malakar","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14357","article-title":"The therapeutic role of nutraceuticals targeting the Nrf2\/HO-1 signaling pathway in liver cancer","volume":"46","author":"Alharbi","year":"2022","journal-title":"J. Food Biochem"},{"key":"10.1016\/j.prp.2024.155226_bib64","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/bjc.2014.383","article-title":"Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ\/PTBP2 complex","volume":"111","author":"Ji","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib65","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/celldisc.2017.2","article-title":"Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity","volume":"3","author":"Chen","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.prp.2024.155226_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2016.05.039","article-title":"MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1","volume":"83","author":"Huang","year":"2016","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopha.2014.04.007","article-title":"MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2\/ASF","volume":"68","author":"Wang","year":"2014","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib68","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4155\/fmc-2021-0128","article-title":"The role of HGF\/MET in liver cancer","volume":"13","author":"Gupta","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.prp.2024.155226_bib69","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.febslet.2013.07.048","article-title":"MALAT-1 interacts with hnRNP C in cell cycle regulation","volume":"587","author":"Yang","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2024.155226_bib70","article-title":"From carcinogenesis to therapeutic avenues: incRNAs and mTOR crosstalk in lung cancer","volume":"253","author":"Hussain","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib71","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155226_bib72","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/CMAR.S169406","article-title":"MALAT1: a potential biomarker in cancer","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2024.155226_bib73","doi-asserted-by":"crossref","first-page":"5515218","DOI":"10.1155\/2021\/5515218","article-title":"Comprehensive characterization of common and cancer-specific differently expressed lncRNAs in urologic cancers","volume":"2021","author":"Yan","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.prp.2024.155226_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109568","article-title":"Nuclear factor-kappa B and its role in inflammatory lung disease","volume":"345","author":"Alharbi","year":"2021","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.prp.2024.155226_bib75","doi-asserted-by":"crossref","first-page":"1004212","DOI":"10.3389\/fonc.2022.1004212","article-title":"LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer","volume":"12","author":"Song","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12935-018-0606-z","article-title":"Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2024.155226_bib77","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopha.2018.09.090","article-title":"MicroRNAs as biological regulators in skin disorders","volume":"108","author":"Singhvi","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-018-4839-2","article-title":"High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival","volume":"171","author":"Wang","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2024.155226_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/CMAR.S276795","article-title":"Significance of oncotype DX 21-gene test and expression of long non-coding RNA MALAT1 in early and estrogen receptor-positive breast cancer patients","volume":"13","author":"Huang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2024.155226_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0031-0808.17.03386-9","article-title":"Tumor suppressor role of miR-503","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.prp.2024.155226_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910201","article-title":"LncRNA MALAT1 facilitates ovarian cancer progression through promoting chemoresistance and invasiveness in the tumor microenvironment","volume":"22","author":"Mao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib82","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s13277-014-2925-6","article-title":"Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s13277-015-3870-8","article-title":"Prognostic value of long non-coding RNA MALAT1 in cancer patients","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cbf.3785","article-title":"Dynamic expression of H19 and MALAT1 and their correlation with tumor progression biomarkers in a multistage hepatocarcinogenesis model","volume":"41","author":"El-Daly","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.prp.2024.155226_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1615\/CritRevEukaryotGeneExpr.2018021188","article-title":"Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer","volume":"28","author":"Gupta","year":"2018","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.prp.2024.155226_bib86","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-1542","article-title":"MALAT1 ablation dismantles homologous recombination repair machinery and sensitizes castrate resistant prostate cancer cells to PARP inhibitor","volume":"82","author":"Yadav","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib87","doi-asserted-by":"crossref","first-page":"8693259","DOI":"10.1155\/2022\/8693259","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR axis","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2024.155226_bib88","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.biopha.2018.03.061","article-title":"The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: a review","volume":"102","author":"Chellappan","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib89","doi-asserted-by":"crossref","first-page":"555","DOI":"10.56434\/j.arch.esp.urol.20237608.69","article-title":"The value of combined detection of serum PSA, MALAT1 and TMPRSS2-ETV1 in evaluating the progress and prognosis of prostate cancer","volume":"76","author":"Zhao","year":"2023","journal-title":"Arch. Esp. De. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib90","first-page":"1","article-title":"Current and future burden of prostate cancer in Songkhla, Thailand: analysis of incidence and mortality trends from 1990 to 2030","volume":"4","author":"Alvarez","year":"2018","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib91","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s13277-014-2850-8","article-title":"Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer","volume":"36","author":"Pang","year":"2015","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib92","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.juro.2013.07.001","article-title":"Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer","volume":"190","author":"Ren","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib93","first-page":"3499","article-title":"Silencing of MALAT1 inhibits migration and invasion by sponging miR\u20111\u20113p in prostate cancer cells","volume":"20","author":"Dai","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13046-021-02233-w","article-title":"MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer","volume":"41","author":"Ferri","year":"2022","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.prp.2024.155226_bib95","first-page":"3035","article-title":"Identification of prognostic biomarkers of prostate cancer with long non-coding","volume":"17","author":"Ye","year":"2019","journal-title":"RNA-Mediat. Comp\u00e9t. Endog. RNA Netw., Exp. Ther. Med."},{"key":"10.1016\/j.prp.2024.155226_bib96","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.21037\/tau-20-1526","article-title":"Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib97","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1111\/jcmm.13604","article-title":"Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12","volume":"22","author":"Xue","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib98","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.2147\/OTT.S164131","article-title":"MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS","volume":"11","author":"Chang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155226_bib99","article-title":"MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140\/BIRC6 axis","volume":"123","author":"Hao","year":"2020","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib100","first-page":"22","article-title":"Targeting the MALAT1 gene with the CRISPR\/Cas9 technique in prostate cancer","volume":"44","author":"Ahmadi-Balootaki","year":"2022","journal-title":"Genes Environ. Off. J. Jpn. Environ. Mut. Society"},{"key":"10.1016\/j.prp.2024.155226_bib101","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1541-7786.MCR-14-0273","article-title":"Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer","volume":"13","author":"Sowalsky","year":"2015","journal-title":"Mol. Cancer Res.: MCR"},{"key":"10.1016\/j.prp.2024.155226_bib102","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrurol.2017.91","article-title":"Prostate cancer: escaping enzalutamide: Malat1 contributes to resistance","volume":"14","author":"Stone","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2024.155226_bib103","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.prp.2019.01.011","article-title":"Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells","volume":"215","author":"Dai","year":"2019","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib104","doi-asserted-by":"crossref","first-page":"41045","DOI":"10.18632\/oncotarget.5728","article-title":"LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s12276-022-00837-6","article-title":"MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4\/STAT3 axis","volume":"54","author":"Gan","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.prp.2024.155226_bib106","article-title":"Corrigendum to \"Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction\" [Biomed. Pharmacother. 118(2019)109208]","volume":"151","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib107","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.2147\/OTT.S317234","article-title":"The role and mechanism of MALAT1 long non-coding RNA in the diagnosis and treatment of head and neck squamous cell carcinoma","volume":"14","author":"Ye","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155226_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2017.11.003","article-title":"An update on the molecular pathology of urinary bladder tumors","volume":"214","author":"Yousef","year":"2018","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2024.155226_bib109","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","article-title":"The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biopha.2018.03.138","article-title":"Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143","volume":"103","author":"An","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155226_bib111","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.7150\/ijbs.33772","article-title":"A synthetic light-switchable system based on CRISPR Cas13a regulates the expression of LncRNA MALAT1 and affects the malignant phenotype of bladder cancer cells","volume":"15","author":"Qi","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib112","first-page":"748","article-title":"LncRNA MALAT1 promotes tumor growth and metastasis by targeting miR-124\/foxq1 in bladder transitional cell carcinoma (BTCC)","volume":"8","author":"Jiao","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib113","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/abbs\/gmz112","article-title":"LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p\/VEGF-C pathway in bladder cancer","volume":"51","author":"Liu","year":"2019","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"key":"10.1016\/j.prp.2024.155226_bib114","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.7150\/jca.21228","article-title":"LncRNA MALAT1 inhibits apoptosis and promotes invasion by antagonizing miR-125b in bladder cancer cells","volume":"8","author":"Xie","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.humgen.2023.201164","article-title":"The role of long non-coding RNA UCA1 and MALAT1 in bladder cancer patients","volume":"36","author":"Aboelkhair","year":"2023","journal-title":"Human Gene"},{"key":"10.1016\/j.prp.2024.155226_bib116","doi-asserted-by":"crossref","first-page":"31019","DOI":"10.1039\/C8RA04876B","article-title":"Down-regulated LncR-MALAT1 suppressed cell proliferation and migration by inactivating autophagy in bladder cancer","volume":"8","author":"Qi","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.prp.2024.155226_bib117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.26502\/jcsct.5079016","article-title":"The role of MALAT1 in cancer","volume":"3","author":"Chen","year":"2019","journal-title":"J. Cancer Sci. Clin. Ther."},{"key":"10.1016\/j.prp.2024.155226_bib118","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2147\/CMAR.S369175","article-title":"c-Met: a promising therapeutic target in bladder","volume":"14","author":"Feng","year":"2022","journal-title":"Cancer, Cancer Manag. Res."},{"key":"10.1016\/j.prp.2024.155226_bib119","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clgc.2017.05.001","article-title":"High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer","volume":"15","author":"Li","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib120","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-13-1455","article-title":"TGF-\u03b2-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12","volume":"20","author":"Fan","year":"2014","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib121","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.7150\/jca.25005","article-title":"CIP2A promotes proliferation, invasion and chemoresistance to cisplatin in renal cell carcinoma","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib122","doi-asserted-by":"crossref","first-page":"38005","DOI":"10.18632\/oncotarget.5357","article-title":"LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma","volume":"6","author":"Xiao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib123","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mc.22926","article-title":"LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p\/ACVR2B signaling","volume":"58","author":"Ye","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2024.155226_bib124","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15384101.2020.1792667","article-title":"Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma","volume":"19","author":"Wang","year":"2020","journal-title":"Cell cycle"},{"key":"10.1016\/j.prp.2024.155226_bib125","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8138","article-title":"Mechanism of tumor\u2011derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1","volume":"46","author":"Jin","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib126","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.12659\/MSM.909450","article-title":"Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes renal cell carcinoma progression via sponging miRNA-429","volume":"24","author":"Jiang","year":"2018","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.prp.2024.155226_bib127","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12640","article-title":"MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5","volume":"52","author":"Zhang","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.prp.2024.155226_bib128","article-title":"Prognostic significance of MALAT1 in clear cell renal cell carcinoma based on TCGA and GEO","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2024.155226_bib129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.14348\/molcells.2022.2081","article-title":"The molecular mechanism of long non-coding RNA MALAT1-mediated regulation of chondrocyte pyroptosis in ankylosing spondylitis","volume":"45","author":"Chen","year":"2022","journal-title":"Mol. Cells"},{"key":"10.1016\/j.prp.2024.155226_bib130","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1002\/cam4.1677","article-title":"Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells","volume":"7","author":"Sun","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2024.155226_bib131","doi-asserted-by":"crossref","first-page":"59417","DOI":"10.18632\/oncotarget.19727","article-title":"Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib132","first-page":"1638","article-title":"MALAT1\/miR-320a in bone marrow mesenchymal stem cells function may shed light on mechanisms underlying osteoporosis","volume":"18","author":"Su","year":"2022"},{"key":"10.1016\/j.prp.2024.155226_bib133","article-title":"Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2024.155226_bib134","first-page":"4157606","article-title":"Long noncoding RNA MALAT1 promotes colorectal cancer progression by acting as a ceRNA of miR-508-5p to regulate RAB14 expression","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2024.155226_bib135","first-page":"6671814","article-title":"lncRNA MALAT1 regulates mouse granulosa cell apoptosis and 17\u03b2-estradiol synthesis via regulating miR-205\/CREB1 Axis","volume":"2021","author":"Sun","year":"2021","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2024.155226_bib136","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1518628","article-title":"lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression","volume":"8","author":"Huang","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2024.155226_bib137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12935-020-01549-5","article-title":"Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p\/ADAM17 axis in colorectal cancer cells","volume":"20","author":"Fan","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2024.155226_bib138","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/OTT.S196619","article-title":"lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p","volume":"13","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155226_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117280","article-title":"Propofol facilitates cisplatin sensitivity via lncRNA MALAT1\/miR-30e\/ATG5 axis through suppressing autophagy in gastric cancer","volume":"244","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2024.155226_bib140","first-page":"2601","article-title":"LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384\/GOLM1 axis in glioma","volume":"24","author":"Ma","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib141","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s12035-020-02165-0","article-title":"Long non-coding RNA MALAT1 upregulates ZEB2 expression to promote malignant progression of glioma by attenuating miR-124","volume":"58","author":"Cheng","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2024.155226_bib142","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3892\/mmr.2020.11196","article-title":"lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR\u2011375 sponging","volume":"22","author":"Zhao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib143","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11010-020-03904-6","article-title":"LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p\/Nova1 axis","volume":"476","author":"Cao","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.prp.2024.155226_bib144","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419859699","article-title":"LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p\/programmed death-ligand 1 axis","volume":"33","author":"Wei","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.prp.2024.155226_bib145","first-page":"270","article-title":"LncRNA MALAT1 depressed chemo-sensitivity of NSCLC cells through directly functioning on miR-197-3p\/p120 catenin axis","volume":"42","author":"Yang","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.prp.2024.155226_bib146","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.2147\/CMAR.S242425","article-title":"MALAT1 promotes cell tumorigenicity through regulating miR-515-5p\/EEF2 axis in non-small cell lung","volume":"12","author":"Rong","year":"2020","journal-title":"Cancer, Cancer Manag. Res."},{"key":"10.1016\/j.prp.2024.155226_bib147","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1080\/15384101.2019.1652034","article-title":"LncRNA MALAT1\/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway","volume":"18","author":"Sun","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2024.155226_bib148","doi-asserted-by":"crossref","first-page":"101984","DOI":"10.18632\/oncotarget.21957","article-title":"LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib149","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1159\/000495550","article-title":"LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-Akt signaling pathway","volume":"51","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"key":"10.1016\/j.prp.2024.155226_bib150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biocel.2019.04.004","article-title":"miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt\/\u03b2-catenin signaling pathway","volume":"111","author":"Yang","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2024.155226_bib151","doi-asserted-by":"crossref","unstructured":"F. Tao, X. Tian, S. Ruan, M. Shen, Z. Zhang, miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma, FASEB journal: official publication of the Federation of American Societies for Experimental Biology, (2018) fj201800495RR.","DOI":"10.1096\/fj.201800495RR"},{"key":"10.1016\/j.prp.2024.155226_bib152","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.2147\/CMAR.S401333","article-title":"Regulates the progression and cisplatin resistance of ovarian cancer cells via modulating miR-1271-5p\/E2F5 axis [Retraction]","volume":"14","author":"LncRNA","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2024.155226_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146791","article-title":"MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker","volume":"843","author":"Cervena","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.prp.2024.155226_bib154","article-title":"Long non-coding RNA MALAT1: a key player in liver","volume":"8","author":"Lu","year":"2021","journal-title":"Dis., Front. Med."},{"key":"10.1016\/j.prp.2024.155226_bib155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40364-023-00467-8","article-title":"Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance","volume":"11","author":"Hou","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2024.155226_bib156","first-page":"1365","article-title":"Long non\u2011coding RNA MALAT1 serves as an independent predictive biomarker for the diagnosis, severity and prognosis of patients with sepsis","volume":"21","author":"Chen","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib157","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1007\/s12035-022-02899-z","article-title":"MALAT1 lncRNA and Parkinson's disease: the role in the pathophysiology and significance for diagnostic and therapeutic approaches","volume":"59","author":"Abrishamdar","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2024.155226_bib158","first-page":"1163","article-title":"[Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on Meta-analysis]","volume":"41","author":"Song","year":"2016","journal-title":"Zhong nan da xue xue bao. Yi xue Ban. = J. Cent. South Univ. Med. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib159","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/S0959-8049(16)61659-3","article-title":"The prognostic potential of the long non-coding RNA MALAT1 in prostate cancer","volume":"1","author":"Hiew","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib160","doi-asserted-by":"crossref","unstructured":"E. Mahmoudi, M. Ebrahimi, F.A. Chermahini, E.H. Lazarjani, H. Kabiri, H. Jamshidian, A. Arshi, F.S. Sharifi, F. Raeisi, Clinical Potential of HOTAIR, MALAT1, and UCA1 lncRNAs As a Biomarker to Achieve More Accurate Prognostic Predictions for Liver Cancer, (2021).","DOI":"10.21203\/rs.3.rs-1097561\/v1"},{"key":"10.1016\/j.prp.2024.155226_bib161","article-title":"NEAT1\/MALAT1\/XIST\/PKD--Hsa-Mir-101-3p--DLGAP5 axis as a novel diagnostic and prognostic biomarker associated with immune cell infiltration in bladder","volume":"13","author":"Rao","year":"2022","journal-title":"Cancer, Front. Genet."},{"key":"10.1016\/j.prp.2024.155226_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194744","article-title":"Increased plasma levels of lncRNAs LINC01268, GAS5 and MALAT1 correlate with negative prognostic factors in myelofibrosis","volume":"13","author":"Fantini","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155226_bib163","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/01616412.2021.1948738","article-title":"\u0130, P.E. Ocak, S. Tolunay, Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets","volume":"43","author":"Ak Aksoy","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.prp.2024.155226_bib164","first-page":"5807","article-title":"Long non-coding RNA MALAT1 as a detection and diagnostic molecular marker in various human","volume":"13","author":"Zhao","year":"2020","journal-title":"Cancer.: A Pool. Anal. Based 3255 Subj., OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155226_bib165","doi-asserted-by":"crossref","first-page":"1012181","DOI":"10.3389\/fnut.2022.1012181","article-title":"Serum albumin to globulin ratio prior to treatment as a potential non-invasive prognostic indicator for urological cancers","volume":"9","author":"Xia","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.prp.2024.155226_bib166","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/070674370705200210","article-title":"What's under the ROC? An introduction to receiver operating characteristics curves","volume":"52","author":"Streiner","year":"2007","journal-title":"Can. J. Psychiatry Rev. Can. De. Psychiatr."},{"key":"10.1016\/j.prp.2024.155226_bib167","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/1756-0500-6-518","article-title":"Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer","volume":"6","author":"Weber","year":"2013","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.prp.2024.155226_bib168","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lfs.2016.03.002","article-title":"A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer","volume":"151","author":"Peng","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2024.155226_bib169","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2017.06.055","article-title":"Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer","volume":"490","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2024.155226_bib170","first-page":"418","article-title":"Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer","volume":"46","author":"Miao","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib171","doi-asserted-by":"crossref","first-page":"78850","DOI":"10.18632\/oncotarget.12880","article-title":"Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer","volume":"7","author":"Duan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib172","doi-asserted-by":"crossref","first-page":"41166","DOI":"10.18632\/oncotarget.17083","article-title":"Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib173","doi-asserted-by":"crossref","first-page":"46993","DOI":"10.18632\/oncotarget.16551","article-title":"MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2","volume":"8","author":"Huo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib174","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3892\/ol.2016.4800","article-title":"Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer","volume":"12","author":"Chen","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib175","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.18632\/oncotarget.21013","article-title":"Diagnostic efficacy of long non-coding RNA MALAT-1 in human cancers: a meta-analysis study","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib176","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7150\/jca.37006","article-title":"A panel of urinary long non-coding RNAs differentiate bladder cancer from urocystitis","volume":"11","author":"Yu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib177","first-page":"9443","article-title":"Expression of metastasis-associated lung adenocarcinoma transcript 1 long non-coding RNA in vitro and in patients with non-small cell lung cancer","volume":"15","author":"Lin","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib178","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-017-0674-z","article-title":"Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression","volume":"16","author":"Jen","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib179","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/JTO.0b013e3182307eac","article-title":"The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth","volume":"6","author":"Schmidt","year":"2011","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-017-3151-6","article-title":"A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155226_bib181","doi-asserted-by":"crossref","first-page":"40418","DOI":"10.18632\/oncotarget.9622","article-title":"Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer","volume":"7","author":"Jadaliha","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155226_bib182","first-page":"3174","article-title":"High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer","volume":"7","author":"Zheng","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2024.155226_bib183","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4149\/neo_2016_617","article-title":"Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer","volume":"63","author":"Li","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.prp.2024.155226_bib184","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3892\/mmr.2020.11171","article-title":"Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network","volume":"22","author":"Hu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2024.155226_bib185","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091406","article-title":"Genetic variants of lncRNA MALAT1 exert diverse impacts on the risk and clinicopathologic characteristics of patients with hepatocellular carcinoma","volume":"8","author":"Yuan","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2024.155226_bib186","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijsu.2019.12.008","article-title":"A commentary on \"Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: a systematic review and meta-analysis\" (Int J Surg 2019;72:206-213)","volume":"74","author":"Roy","year":"2020","journal-title":"Int. J. Surg. (Lond., Engl. )"},{"key":"10.1016\/j.prp.2024.155226_bib187","first-page":"63","article-title":"Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1\/2 wild-type primary glioblastomas","volume":"20","author":"Argadal","year":"2020","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.prp.2024.155226_bib188","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/cgt.2015.58","article-title":"Gene therapy for cancer: regulatory considerations for approval","volume":"22","author":"Husain","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2024.155226_bib189","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3892\/ol.2016.4138","article-title":"Novel insight into MALAT-1 in cancer: therapeutic targets and clinical applications","volume":"11","author":"Ren","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155226_bib190","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/jor.23105","article-title":"Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma","volume":"34","author":"Cai","year":"2016","journal-title":"J. Orthop. Res.: Off. Publ. Orthop. Res. Soc."},{"key":"10.1016\/j.prp.2024.155226_bib191","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155226_bib192","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMcibr1603785","article-title":"Targeting a long noncoding RNA in breast cancer","volume":"374","author":"Mendell","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155226_bib193","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.270959.115","article-title":"Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss","volume":"30","author":"Arun","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155226_bib194","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155226_bib195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.gt.3302356","article-title":"siRNA therapeutics: big potential from small RNAs","volume":"12","author":"Ryther","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.prp.2024.155226_bib196","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155226_bib197","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155226_bib198","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/jcp.27117","article-title":"Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2024.155226_bib199","article-title":"Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1\/STAT3\/ FUT4 axis and P-glycoprotein transporters in lung","volume":"13","author":"Ding","year":"2022","journal-title":"Cancer Cells, Front. Pharmacol."},{"issue":"11 (","key":"10.1016\/j.prp.2024.155226_bib200","article-title":"Integrative systems biology approaches to identify potential biomarkers and pathways of cervical cancer","author":"Oany","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.prp.2024.155226_bib201","doi-asserted-by":"crossref","first-page":"5483523","DOI":"10.1155\/2022\/5483523","article-title":"Exosomes derived from tumor cells initiate breast cancer cell metastasis and chemoresistance through a MALAT1-dependent mechanism","volume":"2022","author":"Tao","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.prp.2024.155226_bib202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1021\/acs.bioconjchem.3c00085","article-title":"Propensities of fatty acid-modified ASOs: self-assembly vs albumin binding","volume":"34","author":"Kusznir","year":"2023","journal-title":"Bioconjugate Chem."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:57:59Z","timestamp":1731401879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":202,"alternative-id":["S0344033824001377"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155226","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the genome: MALAT1's role in advancing urologic cancer care","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155226"}}